Home > Press > Institutional Holder Has Liquidated More Than Five Percent Holding in MFIC
MFIC Corporation ("MFIC" or the "Company")(OTCBB: MFIC) announced today that it recently received notification that Pfizer Inc. ("Pfizer") had liquidated its position, approximately 600,000 shares, or approximately 6%, of the outstanding common stock of MFIC.
Institutional Holder Has Liquidated More Than Five Percent Holding in MFIC
NEWTON, MA | Posted on April 2nd, 2007
The Pfizer shares were acquired by its predecessor in interest, G.D. Searle, Inc.
In response to a questionnaire circulated in connection with the preparation of MFIC's 2007 Proxy Statement Pfizer supplied records indicating that it sold the shares in the public market in varying size lots between December 2005 and February 2007.
About MFIC Corporation
MFIC Corporation, through its Microfluidics Division, provides patented and proprietary high performance Microfluidizer® materials processing equipment to the biotechnology, pharmaceutical, chemical, cosmetics/personal care, and food industries. The equipment enables the manufacture and formulation of numerous nanomaterials and nanoscale products. MFIC applies its 20 years of high pressure processing experience to produce the most uniform and smallest liquid and suspended solid structures available, and has provided manufacturing systems for more than 15 years.
The Company is a leader in advanced materials processing equipment for laboratory, pilot scale and manufacturing applications, offering innovative technology and comprehensive solutions for nanoparticles and other materials processing and production. More than 3,000 systems are in use and afford significant competitive and economic advantages to MFIC equipment customers.
For more information, please click here
Irwin Gruverman, CEO & Chairman
Robert P. Bruno, President & COO
Jack M. Swig, Investor Relations
Copyright © Business Wire 2007
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Arrowhead to Report Fiscal 2014 Third Quarter Financial Results- Conference Call Scheduled for Tuesday, August 12, 2014 - July 31st, 2014
Harris & Harris Group Invests in Unique NYC Biotech Accelerator July 29th, 2014
Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 July 23rd, 2014
Nanometrics Announces Upcoming Investor Events July 22nd, 2014
Light pulses control graphene's electrical behavior: Finding could allow ultrafast switching of conduction, and possibly lead to new broadband light sensors August 1st, 2014
President Obama Meets U.S. Laureates of 2014 Kavli Prizes August 1st, 2014
Stanford researchers seek 'Holy Grail' in battery design: Pure lithium anode closer to reality with development of protective layer of interconnected carbon domes August 1st, 2014
Air Force’s 30-year plan seeks 'strategic agility' August 1st, 2014